Last reviewed · How we verify
Test
Test is a medication that works by
Test is a medication that works by Used for Various conditions.
At a glance
| Generic name | Test |
|---|---|
| Also known as | Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, T.R.U.E. TEST, Placebo, HLIM+SA160021 Placebo+SA160022 Placebo, CMT |
| Sponsor | Respirent Pharmaceuticals Co Ltd. |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
It is used to treat various conditions by
Approved indications
- Various conditions
Common side effects
Key clinical trials
- A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases (PHASE3)
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B) (PHASE2)
- Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers (PHASE3)
- Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer (PHASE1)
- Serum Copeptin as Biomarker for Diagnosis and Classification of Polyuric Primary Monosymptomatic Nocturnal Enuresis
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer (PHASE2)
- Immediate Restoration of a New Implant With High Primary Stability (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Test CI brief — competitive landscape report
- Test updates RSS · CI watch RSS
- Respirent Pharmaceuticals Co Ltd. portfolio CI